Related content

miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1

By Zhou Li   Qiu Tianzhu   Xu Jing   Wang Tongshan   Wang Jian   Zhou Xin   Huang Zebo   Zhu Wei   Shu Yongqian   Liu Ping  

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas

By                          

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1072-1078

Spandidos Publications

Access to resources Recommend Favorite

Induced IGF-1R activation contributes to gefitinib resistance following combined treatment with paclitaxel, cisplatin and gefitinib in A549 lung cancer cells

By                        

Oncology Reports, Vol. 32, Iss. 4, 2014-01 ,pp. : 1401-1408

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA106a confers cisplatin resistance in nonsmall cell lung cancer A549 cells by targeting adenosine triphosphatasebinding cassette A1

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 625-632

Spandidos Publications

Access to resources Recommend Favorite

High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma

By Davidson Ben   Goldberg Iris   Gotlieb Walter   Kopolovic Juri   Ben-Baruch Gilad   Nesland Jahn   Berner Aasmund   Bryne Magne   Reich Reuven  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite